To date, there is no functional characterization of TLK2 in breast cancer, although TLK2 single nucleotide polymorphism has been associated with increased breast cancer risk10, and most recently TLK2 has been reported as an amplicon-associated highly phosphorylated kinase in luminal breast cancer11. This evidence concerns the gene TLK2 and breast carcinoma.